Rallybio Corp(RLYB)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Rallybio Corp (RLYB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores RLYB at 70.3/100 on a 32-signal composite quality model, placing it at rank #224 of 2,962 stocks — the top 10% of the AI-ranked universe. Top institutional holders of RLYB by reported 13-F value include ADAR1 Capital Management, FMR, VIKING GLOBAL INVESTORS, based on the most recent SEC filings. RLYB trades on the Nasdaq exchange and files with the SEC under CIK 1739410. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RLYB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Rallybio Corp directly from SEC EDGAR.

AI Quality Score

70.3/100

AI Rank

#224

Revenue

$0.00

Net Income

$43.7M

RLYB key financials by period

Rallybio Corp reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202510-K$858.0K$-9.0M
FY 202410-K$636.0K$-57.8M

Institutions holding RLYB

Institutional investors reporting a position in Rallybio Corp on SEC Form 13F.
InstitutionSharesValueReported
ADAR1 Capital Management926,352$14.8M2026-06-30
FMR794,720$12.7M2026-06-30
VIKING GLOBAL INVESTORS524,347$8.4M2026-06-30
TPG GP A378,551$6.1M2026-06-30
Pivotal bioVenture Partners Investment Advisor300,579$4.8M2026-06-30
RENAISSANCE TECHNOLOGIES199,907$3.2M2026-06-30
Nantahala Capital Management188,422$3.0M2026-06-30
VANGUARD CAPITAL MANAGEMENT172,497$2.8M2026-06-30
Almitas Capital120,682$1.9M2026-06-30
Rangeley Capital104,850$1.7M2026-06-30
RLYB

Rallybio Corp

RLYB
NasdaqSmall CapHealthcare

13F Pro Quality Score

70.3/100

Rank #224 of 2,962 stocksTOP 10%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$0

Net Income

Q2 2026
EDGAR

$43.66M

EPS (Diluted)

Q2 2026
EDGAR

$7.53

ROIC

Q2 2026
EDGAR

-23.9%

Top Institutional Holders

as of Q2 2026
$65.04M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…